Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic Cyanoacrylate vs BRTO for Acute Gastric Variceal Bleeding
NCT02468167Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2015
- Primary completion
- Jul 2020
- Modality
- Injectable Hydrogels, Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of N-butyl-2-cyanoacrylate and polidocanol in gastric varices and Gastrointestinal Bleeding (GIB) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Failure to control acute bleeding or failure to prevent clinically significant variceal rebleeding at 1 year. Status: unknown.
02
Drugs
N-butyl-2-cyanoacrylatepolidocanol
03
Conditions
gastric varicesGastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT02468167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468167.